However, it is important to note that the rapid metabolism of D-serine by the enzyme D-amino acid oxidase (DAAO) may reduce its bioavailability, potentially posing a challenge for its therapeutic use in schizophrenia [102]. The gene discussed is DAO; the disease is schizophrenia.